Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-16

FDA Approved: LODOCO — Original Application (AGEPHA Pharma USA, LLC)

View source ↗

Summary

FDA approved LODOCO (colchicine tablets 0.5 mg) under an original NDA from AGEPHA Pharma USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LoDoCo (colchicine)

Snippet

ORIG AP for LODOCO (COLCHICINE TABLETS 0.5 MG)